Your session is about to expire
← Back to Search
Etravirine Access for HIV
Study Summary
This trial is to provide etravirine until participants can be switched to a different, commercially available treatment.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2018 Phase 4 trial • 545 Patients • NCT01641367Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I completed a pediatric trial with ETR and it's still benefiting me.My child understands the study and agrees to participate.I do not have any serious health conditions that could make treatment unsafe for me.I am at least 2 years old.I am a male, sexually active with women, not vasectomized, and not using or willing to use birth control during and 30 days post-trial.I am using or willing to use effective birth control during and 30 days after the trial.
- Group 1: Etravirine
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are participating in this test?
"Currently, this trial is not enrolling new patients. The listing was created on December 9th 2009 and updated October 25th 2022. There are presently 503 studies actively recruiting patients with hiv infections and 2 studies for Etravirine that are also looking for participants."
Are there any side effects to taking Etravirine?
"There is some efficacy data and multiple rounds of safety data available from Phase 3 trials, so our team has rated the safety of Etravirine as a 3."
Can patients still join this experiment?
"According to data on clinicaltrials.gov, this study is not accepting patients at the moment. This particular trial was initially posted on December 9th 2009 and updated as recently as October 25th 2022. Even though this study isn't looking for participants right now, there are 505 other trials that are currently recruiting patients."
What sort of precedents does this research have?
"Etravirine is being studied in 2 ongoing trials involving 180 patients from 2009. So far, 45 total trials have completed across 6 cities and 12 countries."
Are there any similar drugs to Etravirine?
"Research into etravirine began in 2009 through the study registered under NCT00980538. As of now, there have been 45 completed studies with 2 ongoing ones; many of these taking place in Washington D.C"
Could you provide the number of sites where this research is being conducted in America?
"This study is currently looking for participants from 5 recruitment sites, which are situated in Washington, Montreal and Philadelphia as well as other cities. If you're interested in enrolling, try to select the clinic that is most conveniently located to reduce travel time and costs."
Share this study with friends
Copy Link
Messenger